AstraZeneca / Oxford's Covid-19 vaccine manufactured in India, January 21, 2021. -
Rafiq Maqbool / AP / SIPA
In view of the fears that vaccines against Covid-19 may inspire, AstraZeneca has carried out a demining operation.
The British pharmaceutical company defended on Monday evening the effectiveness of its vaccine for people over 65 years old, denying the claims of two German media that Berlin questions the performance of the product for this age group.
"The articles according to which the efficacy of the AstraZeneca / Oxford vaccine is only 8% in adults over 65 are completely false," said a spokesperson for AstraZeneca.
Embed
The newspaper
Bild Zeitung
and the business daily
Handelsblatt
said Monday evening that the German government doubted the effectiveness of this vaccine on people over the age of 65.
According to
Handelsblatt
, who refers to government sources, Berlin expects an efficiency of 8% for this age group.
Bild Zeitung
, also under cover of government sources, writes that Angela Merkel's coalition expects the vaccine, due to receive the EU regulatory green light on Friday, not to be licensed for those over 65 .
European Union dissatisfaction
The British laboratory, whose vaccine is already authorized and widely deployed in the United Kingdom, further explains in its press release that it published scientific data in the journal
The Lancet
in November
, "showing that the elderly have shown strong immune responses to vaccine, 100% of which generated specific antibodies after the second dose ”.
Still on its vaccine, AstraZeneca is also at the heart of another controversy.
The laboratory was the subject of a call to order from the European Commission on Monday after announcing last week that deliveries of its vaccine would be smaller than expected in the first quarter.
Joe Biden expects this summer to achieve collective immunity in the United States
Delays in delivery of AstraZeneca vaccines "not acceptable" denounces the European Union
Video
Covid 19
Coronavirus
Health
Anti-covid vaccine
Germany